Male-biased Yap1-Cd276/B7-H3 axis for immune evasion in medulloblastoma

A study published in Cancer Cell by Abdelfattah and colleagues has identified a sex-biased mechanism of immune evasion in Sonic Hedgehog (SHH) medulloblastoma, revealing that male tumors preferentially rely on the YAP1 transcription co-activator to upregulate the immune checkpoint molecule CD276 (B7-H3). The research demonstrates that immune checkpoint molecules in medulloblastoma cancer cells are expressed in a sex-dependent manner, which may help explain known differences in outcomes between male and female patients. These findings position biological sex as a critical variable in tumor-immune interactions and could have direct implications for the design of immunotherapy trials targeting pediatric brain tumors. The work suggests that future clinical strategies, including anti-B7-H3 therapies currently in development, may need to be stratified by sex to achieve optimal efficacy.